Table 5

Extended-Risk Subgroup 1-Year Clinical Outcomes

STCD/MI (ARC)CD/MI (WHO)TLF (ARC)TLF (WHO)MI (ARC)MI (WHO)TLRTVR, Non-TLR
Lesion length >28 mm (n = 384)1.62%9.4%5.3%11.8%8.8%8.8%3.7%5.3%1.6%
RVD <2.5 mm (n = 183)0.00%5.5%1.6%8.2%4.4%4.9%1.1%3.3%1.6%
RVD >4.25 mm (n = 59)1.79%3.6%1.8%8.9%8.9%1.8%0.0%7.1%3.6%
CTO (n = 130)0.80%3.1%0.8%7.1%4.7%2.4%0.0%3.9%0.8%
Graft (n = 270)1.53%13.3%7.4%18.9%16.7%11.5%5.6%11.5%1.9%
Bifurcation with side branch ≥2 mm (n = 403)1.80%7.7%4.6%9.9%8.2%6.4%3.1%5.4%4.3%
Ostial (n = 688)1.21%8.6%4.6%12.3%10.4%7.6%3.4%7.1%2.4%
Left main (n = 110)0.95%13.9%4.6%19.4%18.5%11.1%1.9%14.8%1.9%
ISR (n = 387)1.60%8.1%3.4%16.0%14.2%7.3%2.4%12.6%3.9%
>2 lesions in same vessel (n = 135)0.77%11.2%6.7%13.4%9.7%9.0%4.5%3.7%2.2%
>2 vessels treated (n = 659)1.72%9.9%4.6%13.1%9.7%9.0%3.2%7.4%4.5%
AMI (n = 673)1.10%9.1%4.2%9.1%7.0%7.4%2.4%4.1%1.5%
Renal insufficiency (n = 518)2.22%13.1%7.2%14.9%11.4%10.0%3.3%5.7%2.0%
EF <30% (n = 123)2.59%14.3%10.1%16.0%12.6%10.9%5.0%5.9%3.4%
With staged procedure (n = 257)1.20%10.9%5.4%10.9%9.3%8.9%3.5%6.6%1.6%

CD = cardiac death; CTO = chronic total occlusion; EF = ejection fraction; ISR = in-stent restenosis; other abbreviations as in Tables 2 and 4.

  • ARC-defined definite and probable.

  • TLF = cardiac death, MI attributed to target vessel and clinically indicated TLR.